SEC Form 4 · accession 0001179110-15-008414
Bellerophon Therapeutics, Inc. · BLPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martin Meglasson
Officer — Chief Scientific Officer
Period of report
May 20, 2015
Accepted (ET)
May 22, 2015 · 7:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001600132
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | P | 712 | $8.40 | A | 19,098 | D |
Table II — derivative securities
No Table II lines on this filing.